Haleon (NYSE:HLN) Sets New 52-Week High – Here’s Why

Haleon plc (NYSE:HLN)’s share price reached a new 52-week high on Monday . The stock traded as high as $10.87 and last traded at $10.84, with a volume of 1639366 shares changing hands. The stock had previously closed at $10.80.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HLN. HSBC reissued a “hold” rating on shares of Haleon in a research report on Wednesday, March 5th. Barclays reissued an “overweight” rating on shares of Haleon in a research report on Tuesday, May 6th. Morgan Stanley raised shares of Haleon from an “equal weight” rating to an “overweight” rating and set a $11.25 price target on the stock in a research report on Friday, May 9th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Haleon in a research report on Monday, March 3rd. Finally, Hsbc Global Res downgraded shares of Haleon from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Five analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $11.25.

Haleon Stock Up 1.2%

The company has a market capitalization of $49.63 billion, a PE ratio of 32.38, a P/E/G ratio of 2.82 and a beta of 0.24. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The stock’s fifty day moving average is $10.25 and its two-hundred day moving average is $9.88.

Haleon (NYSE:HLN) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The company had revenue of $3.54 billion for the quarter, compared to analysts’ expectations of $3.38 billion. As a group, analysts predict that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The business also recently declared a — dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be issued a $0.1166 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a yield of 1.6%. This is a boost from Haleon’s previous — dividend of $0.05. Haleon’s payout ratio is 58.97%.

Hedge Funds Weigh In On Haleon

Several institutional investors and hedge funds have recently added to or reduced their stakes in HLN. Ritholtz Wealth Management increased its holdings in Haleon by 128.1% in the 4th quarter. Ritholtz Wealth Management now owns 59,214 shares of the company’s stock worth $565,000 after buying an additional 33,249 shares in the last quarter. Merit Financial Group LLC bought a new stake in Haleon in the 4th quarter worth about $152,000. HB Wealth Management LLC increased its holdings in Haleon by 27.1% in the 4th quarter. HB Wealth Management LLC now owns 64,402 shares of the company’s stock worth $614,000 after buying an additional 13,743 shares in the last quarter. Ameritas Advisory Services LLC increased its holdings in Haleon by 14.1% in the 4th quarter. Ameritas Advisory Services LLC now owns 18,307 shares of the company’s stock worth $175,000 after buying an additional 2,262 shares in the last quarter. Finally, Aaron Wealth Advisors LLC increased its holdings in Haleon by 11.4% in the 4th quarter. Aaron Wealth Advisors LLC now owns 32,718 shares of the company’s stock worth $312,000 after buying an additional 3,344 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.